Proventil
(albuterol Sulfate)PreclinicalSmall molecule
Mylan Pharmaceuticals IncAlbuterol sulfate is a rescue inhaler used to quickly relieve breathing problems and wheezing in people with asthma or other breathing conditions. It works by relaxing the muscles around the airways to make breathing easier.[1] Proventil is currently being investigated across 1 indication[3], with its most advanced program in Preclinical.[1]
Proventil is one of 16 small molecule programs targeting COVID-19. It is currently in Preclinical.
1
Indications
23
Total Trials
2
Active Trials
15
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
317 competitors in COVID-19
#DrugCompanyPhaseTrials
1Blood Taken
HHospices Civils de Lyon
Preclinical
Other Tkis
BayerPreclinical
Proventil
Mylan Pharmaceuticals IncPreclinical
Serology
UUniversity Hospital Center of Martinique
Preclinical
Pfizer-Biontech COVID-19 MRNA Vaccine
PfizerPreclinical
Huashi Baidu Granule
XXiyuan Hospital of China Academy of Chinese Medical Sciences
Preclinical
Administration of Almitrine
CCentre Hospitalier Universitaire de Nice
Preclinical
Tpa
UUniversity of Florida
Preclinical
Thrombolytic
FFaculty Hospital Kralovske Vinohrady
Preclinical
Coronavac COVID-19 Vaccine
HHospital Moinhos de Vento
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Asthma6 trials
Show 3 more trials
Chronic Obstructive Pulmonary Disease3 trials
Treatment1 trial
Cardiovascular1 trial
A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems
Terminated·—·Phase 1·NCT03098680·18 enrolled
10 more indications
BPD1 trial
Aerosolized Albuterol Use in Severe BPD
Completed·—·N/A·NCT02766673·24 enrolled
Pediatric1 trial
High Flow Nasal Cannula1 trial
Efficacy and Safety1 trial
Exercise1 trial
COVID-191 trial
COPD Exacerbation1 trial
Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Patients Presenting to the Emergency Department With Acute Exacerbation of COPD (ECOPD): A Phase IV, Prospective, Randomized, Blinded, Parallel-group Trial
Not yet recruiting·UUniversity of Tennessee Graduate School of Medicine·Approved·NCT07721922·280 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for albuterol Sulfate. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Mechanism of Action
- Beta-2 Adrenergic Receptor Agonist[2]
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company